Don't get me started... "That guy at Emory" actually managed to "match" a control group, who only got half as much Dexamethasone as the LD-RT cohort.
Dexamethasone, the only drug that was (back then) proven truly beneficial for COVID.
95% of the LDRT and only 50% of the "matched" control group got it.
View attachment 423123
And then, the main conclusion of this paper was
"Adding LD-RT to standard drug treatments reduced biomarkers of inflammation"
Perhaps "adding LD-RT" was not the crucial part. Perhaps doubling the amount of people that got dexamethasone also reduced biomarkers of inflammation?
Also interesting, in the Emory-paper:
An ongoing phase III trial has been powered based on these findings. A sample size of 150 randomized patients will be used to determine LD-RT’s effect on intubation rates and intubation-free survival.
Where is that trial?
But "that guy at Emory" was not the only one.
Matthew Katz kept talking about the trial that he was running on LDRT for COVID.
View attachment 423124
clinicaltrials.gov
Did anyone ever see any of the results?
Spoiler: None were ever published.
Actually, we had a wonderful thread about those trials. Good times!
Any academics in COVID hotspots got the motivation and balls to start a clinical trial ASAP on use of low dose ionizing radiation (LD IR) to treat COVID patients who are on ventilator or close to needing a ventilator?? Once you are on a vent, it is extremely tough to recover.
Low dose ionizing radiation is known to modulate downstream anti-inflammatory processes. We've used it to treat other benign disease processes (Keloids, heterotopic ossification, etc). I'm not academic anymore, so I have no easy access to start a clinical trial.
Here is a review article on historical use...